Connect with us

Government

How public health partnerships are encouraging COVID-19 vaccination in Mississippi, Michigan, Indiana and South Carolina

Achieving widespread immunity to COVID-19 through vaccination requires as many people as possible to get their shots, including those who object or haven’t bothered.

Published

on

A Delta Health Center worker at a pop-up COVID-19 vaccination clinic in rural Mississippi in April 2021. Spencer Platt/Getty Images

About 18 months into the coronavirus pandemic, roughly 61% of all Americans have gotten at least one dose of a COVID-19 vaccine. In some states, however, the share of vaccinated people is as low as 43.6%. There are many counties where numbers are even lower than that, leaving them especially vulnerable to surges in coronavirus infections, hospitalizations and deaths. Here, four public health and communications experts from Michigan, Indiana, Mississippi and South Carolina explain how they are teaming up with nonprofits and other partners to encourage more people in their states and local communities to get these potentially lifesaving shots.

1. Closing the racial gap in Michigan’s COVID-19 vaccination

Debra Furr-Holden, professor of public health, Michigan State University

Initially, Michigan was one of many states with tremendous racial disparities in COVID-19 cases and deaths. As a result, the state tried to make it easier for Blacks and other people of color to get tested, acquire personal protective equipment and, once vaccines became available, get vaccines.

But as an epidemiologist who participated in the partnerships formed between the government, academics, health care professionals, nonprofits and philanthropic funders, I’m concerned because African Americans are still disproportionately getting COVID-19 and dying from it. And despite our concerted efforts, I’m troubled by the big gap between vaccination rates for Black people and white people in Michigan, even if these differences by race and ethnicity are dissipating across the country overall.

About 13% of Michigan residents are Black, and yet 10% of the people in the state who had gotten at least one dose of a vaccine by Aug. 16, 2021 were Black, according to the Kaiser Foundation.

This imbalance is one reason why I helped launch the National Network to Innovate for COVID-19 and Adult Vaccine Equity, funded with a $6 million grant from the Centers for Disease Control and Prevention. One overarching goal of this project is to close the racial disparities gap in COVID-19 and other adult vaccinations, such as the flu and shingles.

The project is a partnership between Michigan State University, Michigan Public Health Institute, the Community Foundation of Greater Flint and Community Campus Partnerships for Health. It also partners with organizations committed to reducing African American health disparities, including the NAACP, the Rainbow PUSH Coalition and the National Medical Association.

A woman wearing a mask gets a COVID-19 vaccine
Takalya Faulkner receives a dose of the Pfizer COVID-19 vaccine on Aug. 24, 2021 in Southfield, Mich. Emily Elconin/Getty Images

2. Outreach to Latinos and members of the Haitian community in Indiana

Omolola Adeoye-Olatunde, assistant professor of pharmacy practice, Purdue University

Marion County, which includes Indianapolis, is racially and ethnically diverse, with nearly half the population identifying as people of color. Even before the COVID-19 pandemic, it had Indiana’s highest level of food insecurity. As of mid-August, Black and Latino residents were underrepresented among people in Indiana who had gotten at least one COVID-19 vaccine dose. Roughly half of all people in Marion County had gotten at least one dose by late August 2021.

The Purdue University Center for Health Equity and Innovation, or CHEqI, where I work, partnered with the Gleaners Food Bank of Indiana and Walgreens to design and pilot an initiative that gave COVID-19 vaccines to people arriving for drive-thru food distribution.

Across the pilot’s first six vaccination events occurring between June and August 2021, 2,787 families got food and 2,465 of the food bank’s clients were asked about their vaccination status and interest by student pharmacists. About 60% said they’d already been vaccinated; 229 of them got vaccines by Walgreens pharmacy staff, with 14% being second-dose vaccinations.

Nearly 60% of the people who got the pilot’s vaccines and reported their ethnicity self-identified as Hispanic or Latino.

Numbers of vaccinations have declined since the first events in June, but student volunteers and Walgreens staff have observed that several clients who received vaccines were previously reluctant to get them. For example, one food bank client indicated they had recently canceled a scheduled vaccine appointment due to hesitancy. Upon talking to student pharmacists and Walgreens pharmacy staff for 10 minutes, and having all of their concerns addressed, they decided to get the vaccine at a Gleaners vaccine event.

We will expand this model to another central Indiana location in late August 2021. There, we should be able to serve not just more Latinos, but many members of the Haitian immigrant community and other food-insecure people. Later, we plan to try integrating access to donated food with other public health initiatives.

I believe that this collaborative model, built on longstanding trust between Gleaners and its clients, serves as a promising avenue to simultaneously address food insecurity, decrease vaccine hesitancy, increase access to COVID-19 vaccines and promote health equity in central Indiana.

People protest mandates related to COVID-19.
Many people in Indiana, like these at a Bloomington protest in June 2021, are leery of getting vaccinated against COVID-19. Jeremy Hogan/SOPA Images/LightRocket via Getty Images

3. Navigating the Mississippi RIVER

David Buys, associate professor of health, Mississippi State University

By Aug. 24, 2021, 44.8% of Mississippi residents had gotten at least one shot of the COVID-19 vaccine. With one of the country’s lowest vaccination rates, my state’s latest outbreak is filling up hospitals.

Mississippi State University is trying to increase the vaccination rate by partnering with the Delta Health Alliance, a public health nonprofit that serves communities in Mississippi and western Tennessee. Together, we are spreading awareness about the importance and safety of getting vaccinated on campus and in all 82 of the state’s counties, especially 32 counties in eastern Mississippi.

The new Mississippi RIVER project – RIVER stands for Recognizing Important Vaccine and Education Resources – includes more than 20 students and others who are paid vaccination ambassadors. During the 2021-2022 school year, they are educating their classmates, answering frequently asked questions and encouraging their peers to visit pop-up clinics.

This partnership is funded by the Health Resources and Services Administration, a federal agency. In turn, it is funding incentives for Mississippi State students to get their shots, such as $250 in bookstore coupons or a chance to win a $9,000 tuition discount through a raffle.

Additionally, through this partnership, my university’s extension service, where I do most of my work for the state, is leveraging our reach across Mississippi, including through one-on-one conversations with community members at local workplaces, festivals and other events.

Man in mask eyes man in suit.
Mississippi State Health Officer Dr. Thomas Dobbs responds to a question during a news briefing regarding his state’s COVID-19 response in Jackson, in August 2021. AP Photo/Rogelio V. Solis

4. Identifying barriers through focus groups in South Carolina

Brooke W. McKeever, associate professor of communication, University of South Carolina

Toward the end of August 2021, South Carolina ranked 41st in the U.S. in terms of the percentage of the population that had been fully vaccinated. According to state health authorities, 60.5% of all adults had gotten at least one COVID-19 vaccine dose by Aug. 20 but there are counties with much lower vaccination rates.

Researchers at the Prevention Research Center at the University of South Carolina are working with the South Carolina Community Health Worker Association, Palmetto AIDS Life Support Services and others to increase COVID-19 vaccination throughout the state.

Vice President Kamala Harris, wearing a mask, meets with several people at a pop-up vaccination clinic.
Vice President Kamala Harris, left, and Walgreens executives visit a pop-up COVID-19 vaccination site at the YMCA of Greenville, S.C. in June 2021. Alex Wong/Getty Images

Together, we are working to learn what barriers still exist, what misinformation may be spreading in various communities, how we can increase trust and convince those who have not been vaccinated to get their shots amid an alarming outbreak.

Based on what we learn through focus groups, we will work with community health workers to address misinformation and communicate with those who still have concerns that are keeping them from getting vaccinated. If there are other barriers, such as access to vaccines, we will address those, too.

We are building on a wide array of partnerships – with churches, nonprofits, a community advisory board and academic researchers – to gain access to trusted individuals who can serve as important sources of health information in communities that might be difficult to reach otherwise.

Our Prevention Research Center is one of many throughout the U.S. that have been funded by the Centers for Disease Control and Prevention as part of its COVID-19 Vaccinate with Confidence Strategy program. We hope our work with the CDC, state agencies and local nonprofits will get more South Carolina residents vaccinated, which will help protect us all moving forward.

[Research into coronavirus and other news from science Subscribe to The Conversation’s new science newsletter.]

Debra Furr-Holden receives funding from the Centers for Disease Control and Prevention and the National Institutes of Health.

Brooke W. McKeever receives funding from the Centers for Disease Control and Prevention.

David R. Buys receives funding from the Health Services and Research Administration via the Delta Health Alliance, Extension Foundation, National Institutes of Health, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Agency, and the United States Department of Agriculture.

Omolola Adeoye-Olatunde receives funding from the Indiana Clinical and Translational Sciences Institute, Indiana Department of Health, and the Marion County Public Health Department.

Read More

Continue Reading

Government

Student Loan Forgiveness Is Robbing Peter To Pay Paul

Student Loan Forgiveness Is Robbing Peter To Pay Paul

Via SchiffGold.com,

With President Biden’s Saving on a Valuable Education (SAVE)…

Published

on

Student Loan Forgiveness Is Robbing Peter To Pay Paul

Via SchiffGold.com,

With President Biden’s Saving on a Valuable Education (SAVE) plan set to extend more student loan relief to borrowers this summer, the federal government is pretending it can wave a magic wand to make debts disappear. But the truth of student debt “relief” is that they’re simply shifting the burden to everyone else, robbing Peter to pay Paul and funneling more steam into an inflation pressure cooker that’s already set to burst.

Starting July 1st, new rules go into effect that change the discretionary income requirements for their payment plans from 10% to only 5% for undergraduates, leading to lower payments for millions. Some borrowers will even have their owed balances revert to zero.

What the plan doesn’t describe, predictably, is how that burden will be shifted to the rest of the country by stealing value out of their pockets via new taxes or increased inflation, which still simmering well above levels seen in early 2020 before the Fed printed trillions in Covid “stimulus” money. They’re rewarding students who took out loans they can’t afford and punishing those who paid their way or repaid their loans, attending school while living within their means. And they’re stealing from the entire country to finance it.

Biden actually claims that a continuing Covid “emergency” is what gives him the authority to offer student loan forgiveness to begin with. As with any “temporary” measure that gives state power a pretense to grow, or gives them an excuse to collect more revenue (I’m looking at you, federal income tax), COVID-19 continues to be the gift that keeps on giving for power and revenue-hungry politicians even as the CDC reclassifies the virus as a threat similar to the seasonal flu.

The SAVE plan takes the burden of billions of dollars in owed payments away from students and adds it to a national debt that’s already ballooning to the tune of a mind-boggling trillion dollars every 3 months. If all student loan debt were forgiven, according to the Brookings Institution, it would surpass the cumulative totals for the past 20 years for multiple existing tax credits and welfare programs:

“Forgiving all student debt would be a transfer larger than the amounts the nation has spent over the past 20 years on unemployment insurance, larger than the amount it has spent on the Earned Income Tax Credit, and larger than the amount it has spent on food stamps.”

Ironically enough, adding hundreds of billions to the national debt from Biden’s program is likely to cause the most pain to the very demographics the Biden administration claims to be helping with its plan: poor people, anyone who skipped college entirely or paid their loans back, and other already overly-indebted young adults, whose purchasing power is being rapidly eroded by out-of-control government spending and central bank monetary shenanigans. It effectively transfers even more wealth from the poor to the wealthy, a trend that Covid-era measures have taken to new extremes.

As Ron Paul pointed out in a recent op-ed for the Eurasia Review:

“…these loans will be paid off in part by taxpayers who did not go to college, paid their own way through school, or have already paid off their student loans. Since those with college degrees tend to earn more over time than those without them, this program redistributes wealth from lower to higher income Americans.”

Even some progressives are taking aim at the plan, not because it shifts the debt burden to other Americans, but because it will require cutting welfare or sacrificing other expensive social programs promised by Biden such as universal pre-K. For these critics, the issue isn’t so much that spending and debt are totally out of control, but that they’re being funneled into the wrong issues.

Progressive “solutions” always seem to take the form of slogans like “tax the wealthy,” a feel-good bromide that for lawmakers always seems to translate into increased taxes for the middle and lower-upper class. Meanwhile, the .01% continue to avoid taxes through offshore accounts, money laundering trickery dressed up as philanthropy, and general de facto ownership of the system through channels like political donations and aggressive lobbying.

If new waves of college applicants expect loan forgiveness plans to continue, it also encourages schools to continue raising tuition and motivates prospective students to continue with even more irresponsible borrowing.

This puts pressure on the Fed to keep interest rates lower to help accommodate waves of new student loan applicants from sparkly-eyed young borrowers who figure they’ll never really have to pay the money back.

With the Fed already expected to cut rates this year despite inflation not being properly under control, the loan forgiveness scheme is just one of many factors conspiring to cause inflation to start running hotter again, spiraling out of control, as the entire country is forced to pay the hidden tax of price increases for all their basic needs.

Tyler Durden Wed, 03/13/2024 - 06:30

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

Trending